Responses
Clinical and epidemiological research
Extended report
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)
Compose a Response to This Article
Other responses
No responses have been published for this article.